Patents by Inventor Anders Sågström

Anders Sågström has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transdermal drug administration device
    Patent number: 10736838
    Abstract: A transdermal drug administration device comprising a drug delivery element (10) defining a contact surface (12) for location, in use, against a patient's skin. The drug delivery element (10) includes a sustained-release pharmaceutical composition. The composition comprises a network of a carrier material having a high mechanical strength and an active pharmaceutical ingredient. The active pharmaceutical ingredient is co-formedly interspersed within pores in the solid, continuous network of the carrier material.
    Type: Grant
    Filed: April 5, 2019
    Date of Patent: August 11, 2020
    Assignee: Emplicure AB
    Inventors: Håkan Engqvist, Susanne Bredenberg, Anders Petterson, Thomas Lundqvist, Anna Dahlgren, Anders Sågström
  • Abuse resistant formula
    Patent number: 10543203
    Abstract: There is provided a sustained-release pharmaceutical composition comprising a solid, continuous network comprising an excipient with a high mechanical strength, which network also comprises pores, within which pores is interspersed a mixture of an active ingredient and a film-forming agent, characterised in that said pores are formed during the production of the composition. Compositions of the invention find particularly utility as abuse-resistant formulations comprising opioid analgesics that may be employed in the treatment of chronic pain.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: January 28, 2020
    Assignee: Emplicure AB
    Inventors: Susanne Bredenberg, Anna Dahlgren, Anders Sågström, Håkan Engqvist
  • TRANSDERMAL DRUG ADMINISTRATION DEVICE
    Publication number: 20190282494
    Abstract: A transdermal drug administration device comprising a drug delivery element (10) defining a contact surface (12) for location, in use, against a patient's skin. The drug delivery element (10) includes a sustained-release pharmaceutical composition. The composition comprises a network of a carrier material having a high mechanical strength and an active pharmaceutical ingredient. The active pharmaceutical ingredient is co-formedly interspersed within pores in the solid, continuous network of the carrier material.
    Type: Application
    Filed: April 5, 2019
    Publication date: September 19, 2019
    Inventors: Håkan Engqvist, Susanne Bredenberg, Anders Petterson, Thomas Lundqvist, Anna Dahlgren, Anders Sågström
  • Transdermal drug administration device
    Patent number: 10251834
    Abstract: A transdermal drug administration device comprising a drug delivery element (10) defining a contact surface (12) for location, in use, against a patient's skin. The drug delivery element (10) includes a sustained-release pharmaceutical composition. The composition comprises a network of a carrier material having a high mechanical strength and an active pharmaceutical ingredient. The active pharmaceutical ingredient is co-formedly interspersed within pores in the solid, continuous network of the carrier material.
    Type: Grant
    Filed: September 5, 2011
    Date of Patent: April 9, 2019
    Assignee: EMPLICURE AB
    Inventors: Håkan Engqvist, Susanne Bredenberg, Anders Pettersson, Thomas Lundqvist, Anna Dahlgren, Anders Sågström
  • ABUSE RESISTANT FORMULA
    Publication number: 20170239229
    Abstract: There is provided a sustained-release pharmaceutical composition comprising a solid, continuous network comprising an excipient with a high mechanical strength, which network also comprises pores, within which pores is interspersed a mixture of an active ingredient and a film-forming agent, characterised in that said pores are formed during the production of the composition. Compositions of the invention find particularly utility as abuse-resistant formulations comprising opioid analgesics that may be employed in the treatment of chronic pain.
    Type: Application
    Filed: March 9, 2017
    Publication date: August 24, 2017
    Inventors: Susanne BREDENBERG, Anna DAHLGREN, Anders SÅGSTRÖM, Håkan ENGQVIST
  • Abuse resistant formula
    Patent number: 9622972
    Abstract: There is provided a sustained-release pharmaceutical composition comprising a solid, continuous network comprising an excipient with a high mechanical strength, which network also comprises pores, within which pores is interspersed a mixture of an active ingredient and a film-forming agent, characterized in that said pores are formed during the production of the composition. Compositions of the invention find particularly utility as abuse-resistant formulations comprising opioid analgesics that may be employed in the treatment of chronic pain.
    Type: Grant
    Filed: March 2, 2010
    Date of Patent: April 18, 2017
    Assignee: Emplicure AB
    Inventors: Susanne Bredenberg, Anna Dahlgren, Anders Sågström, Håkan Engqvist
  • TRANSDERMAL DRUG ADMINISTRATION DEVICE
    Publication number: 20130273119
    Abstract: A transdermal drug administration device comprising a drug delivery element (10) defining a contact surface (12) for location, in use, against a patient's skin. The drug delivery element (10) includes a sustained-release pharmaceutical composition. The composition comprises a network of a carrier material having a high mechanical strength and an active pharmaceutical ingredient. The active pharmaceutical ingredient is co-formedly interspersed within pores in the solid, continuous network of the carrier material.
    Type: Application
    Filed: September 5, 2011
    Publication date: October 17, 2013
    Applicant: OREXO AB
    Inventors: Häkan Engqvist, Susanne Bredenberg, Anders Pettersson, Thomas Lundqvist, Anna Dahlgren, Anders Sågström